Results 181 to 190 of about 29,994,236 (203)

The mTOR Complex Controls HIV Latency [PDF]

open access: yesCell Host and Microbe, 2016
A population of CD4 T lymphocytes harboring latent HIV genomes can persist in patients on antiretroviral therapy, posing a barrier to HIV eradication.
Michael C Bassik   +2 more
exaly   +2 more sources

Novel Triazolopyridine-Based BRD4 Inhibitors as Potent HIV-1 Latency Reversing Agents

ACS Medicinal Chemistry Letters, 2023
Bromodomain-containing protein 4 (BRD4) inhibitors have been proven to be a promising option for anti-HIV-1 latency therapeutics. We herein describe the design, synthesis, and anti-HIV-1 latency bioevaluation of triazolopyridine derivatives as BRD4 inhibitors.
Yan-Kai Wang   +13 more
openaire   +2 more sources

Elucidating the mechanisms and dynamics of drug-mediated inhibition and latency reversal in HIV-1 (HIV-1)

2021
[ACCESS RESTRICTED TO THE UNIVERSITY OF MISSOURI AT AUTHOR'S REQUEST.] The Human Immunodeficiency Virus Type-1 (HIV-1) is the etiological agent of Acquired Immunodeficiency Syndrome, a disease that causes the host to succumb to secondary infections. There is currently no cure for HIV-1 infection, but Highly Active Anti-Retroviral Therapy (HAART) can ...
openaire   +2 more sources

Antiretroviral drugs do not interfere with bryostatin-mediated HIV-1 latency reversal

Antiviral Research, 2015
Although an effective combination of antiretroviral therapy (cART) controls HIV-1 viraemia in infected patients, viral latency established soon after infection hinders HIV-1 eradication. It has been shown that bryostatin-1 (BRY) inhibits HIV-infection in vitro and reactivates the latent virus through the protein kinase C-NF-κB pathway.
Marta, Martínez-Bonet   +7 more
openaire   +2 more sources

The BAF complex inhibitor pyrimethamine reverses HIV-1 latency in people with HIV-1 on antiretroviral therapy

2022
Abstract A major barrier towards HIV-1 cure is the presence of a replication-competent latent reservoir that, upon treatment cessation, can spark viral rebound leading to disease progression. Pharmacological reactivation of the latent HIV-1 reservoir with Latency reversing agents (LRAs) is a first step toward ...
H.A.B. Prins   +29 more
openaire   +1 more source

MALAT1 is important for facilitating HIV-1 latency reversal in latently infected monocytes

Gene
Long non-coding RNAs (lncRNAs) are long RNA transcripts with length >200 nucleotides that do not encode proteins. They play a crucial role in regulating HIV-1 infection, yet their involvement in myeloid cells remains underexplored. Myeloid cells are susceptible to HIV infection and contribute substantially to the latent HIV reservoir.
Ankita, Rai   +9 more
openaire   +2 more sources

Modeling latency reversal en HIV-1 infection

2016
info:eu-repo/semantics ...
Ribeiro, Ruy M.   +3 more
openaire   +1 more source

Epigenetic silencing and blockade of latency reversal by an HIV-1 encoded antisense transcript

Abstract The mechanisms that regulate human immunodeficiency virus 1 (HIV-1) latency are not fully elucidated. We reported that an HIV-1 antisense transcript (AST) induces epigenetic modifications at the HIV-1 promoter causing a closed chromatin state that suppresses viral transcription.
Rui, Li   +8 more
openaire   +2 more sources

A novel HIV-1 latency reversing bromodomain inhibitor

2018
Trabajo presentado en la VII Spanish Drug Discovery Network Meeting, celebrada en Barcelona, España, del 12 al 13 de noviembre de ...
Jordan, Albert, Abner, Erik
openaire   +1 more source

Home - About - Disclaimer - Privacy